Rank | Gene Set | Z-score |
---|---|---|
1 | muscle filament sliding (GO:0030049) | 9.18938790 |
2 | actin-myosin filament sliding (GO:0033275) | 9.18938790 |
3 | sarcomere organization (GO:0045214) | 8.73438546 |
4 | cardiac myofibril assembly (GO:0055003) | 8.61448405 |
5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.20189306 |
6 | myofibril assembly (GO:0030239) | 8.02029361 |
7 | actin-mediated cell contraction (GO:0070252) | 7.62976157 |
8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.15612160 |
9 | regulation of skeletal muscle contraction (GO:0014819) | 7.03453717 |
10 | cardiac muscle contraction (GO:0060048) | 6.73636136 |
11 | tricarboxylic acid cycle (GO:0006099) | 6.53283208 |
12 | cardiac muscle cell development (GO:0055013) | 6.41769284 |
13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.39502628 |
14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.36595152 |
15 | regulation of relaxation of muscle (GO:1901077) | 6.09811304 |
16 | plasma membrane repair (GO:0001778) | 6.08536455 |
17 | cardiac cell development (GO:0055006) | 6.03562829 |
18 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.95906564 |
19 | actomyosin structure organization (GO:0031032) | 5.87282029 |
20 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.82814149 |
21 | cardiac muscle hypertrophy (GO:0003300) | 5.80232392 |
22 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.76918129 |
23 | * striated muscle contraction (GO:0006941) | 5.76584288 |
24 | heart process (GO:0003015) | 5.75770588 |
25 | heart contraction (GO:0060047) | 5.75770588 |
26 | regulation of sarcomere organization (GO:0060297) | 5.73180749 |
27 | actin filament-based movement (GO:0030048) | 5.68529434 |
28 | striated muscle hypertrophy (GO:0014897) | 5.56289410 |
29 | regulation of actin filament-based movement (GO:1903115) | 5.54249632 |
30 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.53563859 |
31 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.41324362 |
32 | muscle tissue morphogenesis (GO:0060415) | 5.28149944 |
33 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.25260358 |
34 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.21049864 |
35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.19802901 |
36 | heart trabecula formation (GO:0060347) | 5.14912370 |
37 | regulation of cell communication by electrical coupling (GO:0010649) | 5.14410212 |
38 | adult heart development (GO:0007512) | 5.13128092 |
39 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.10788429 |
40 | carnitine shuttle (GO:0006853) | 5.10271327 |
41 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.07456814 |
42 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.04796538 |
43 | ATP synthesis coupled proton transport (GO:0015986) | 5.04796538 |
44 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.02797955 |
45 | muscle hypertrophy (GO:0014896) | 4.93489992 |
46 | skeletal muscle contraction (GO:0003009) | 4.90762180 |
47 | regulation of striated muscle contraction (GO:0006942) | 4.89209215 |
48 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.80860552 |
49 | oxidative phosphorylation (GO:0006119) | 4.65541955 |
50 | regulation of cofactor metabolic process (GO:0051193) | 4.64944541 |
51 | regulation of coenzyme metabolic process (GO:0051196) | 4.64944541 |
52 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.62626372 |
53 | regulation of membrane repolarization (GO:0060306) | 4.50286878 |
54 | skeletal muscle fiber development (GO:0048741) | 4.48457292 |
55 | respiratory electron transport chain (GO:0022904) | 4.43135626 |
56 | fatty acid transmembrane transport (GO:1902001) | 4.42009800 |
57 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.37243236 |
58 | muscle hypertrophy in response to stress (GO:0003299) | 4.37243236 |
59 | cardiac muscle adaptation (GO:0014887) | 4.37243236 |
60 | regulation of the force of heart contraction (GO:0002026) | 4.36565300 |
61 | electron transport chain (GO:0022900) | 4.31335612 |
62 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.29769004 |
63 | myotube cell development (GO:0014904) | 4.29538579 |
64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.17207804 |
65 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.11379188 |
66 | striated muscle cell development (GO:0055002) | 4.05559056 |
67 | muscle cell cellular homeostasis (GO:0046716) | 4.04819660 |
68 | negative regulation of protein localization to cell surface (GO:2000009) | 3.98719098 |
69 | cell communication involved in cardiac conduction (GO:0086065) | 3.98546655 |
70 | striated muscle adaptation (GO:0014888) | 3.97710921 |
71 | skeletal muscle tissue development (GO:0007519) | 3.95273029 |
72 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.94604117 |
73 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.94604117 |
74 | * muscle contraction (GO:0006936) | 3.92350716 |
75 | regulation of cardioblast differentiation (GO:0051890) | 3.87109701 |
76 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.81139390 |
77 | cytidine metabolic process (GO:0046087) | 3.80519113 |
78 | cytidine catabolic process (GO:0006216) | 3.80519113 |
79 | cytidine deamination (GO:0009972) | 3.80519113 |
80 | response to inactivity (GO:0014854) | 3.80406459 |
81 | cardiac muscle cell action potential (GO:0086001) | 3.77155246 |
82 | glycogen catabolic process (GO:0005980) | 3.76869246 |
83 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.76609746 |
84 | ventricular cardiac muscle cell development (GO:0055015) | 3.76280857 |
85 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76134915 |
86 | carnitine transmembrane transport (GO:1902603) | 3.74853188 |
87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.74768697 |
88 | relaxation of muscle (GO:0090075) | 3.74715062 |
89 | regulation of ATP catabolic process (GO:1903289) | 3.73989859 |
90 | regulation of ATPase activity (GO:0043462) | 3.73989859 |
91 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.73575819 |
92 | regulation of sulfur metabolic process (GO:0042762) | 3.73336258 |
93 | negative regulation of potassium ion transport (GO:0043267) | 3.72894400 |
94 | regulation of heart rate (GO:0002027) | 3.67796491 |
95 | skeletal muscle adaptation (GO:0043501) | 3.67190051 |
96 | * muscle system process (GO:0003012) | 3.67129223 |
97 | glucan biosynthetic process (GO:0009250) | 3.64909334 |
98 | glycogen biosynthetic process (GO:0005978) | 3.64909334 |
99 | regulation of muscle system process (GO:0090257) | 3.64693580 |
100 | regulation of cardiac muscle contraction (GO:0055117) | 3.63464025 |
101 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.62032741 |
102 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.62032741 |
103 | cell communication by electrical coupling (GO:0010644) | 3.57546335 |
104 | creatine metabolic process (GO:0006600) | 3.55842354 |
105 | muscle cell fate commitment (GO:0042693) | 3.54164343 |
106 | glucan catabolic process (GO:0009251) | 3.52995667 |
107 | NADH metabolic process (GO:0006734) | 3.49668029 |
108 | muscle adaptation (GO:0043500) | 3.49457657 |
109 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.49267508 |
110 | relaxation of cardiac muscle (GO:0055119) | 3.48121719 |
111 | muscle cell development (GO:0055001) | 3.46951110 |
112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.41713804 |
113 | regulation of heart contraction (GO:0008016) | 3.41690814 |
114 | carnitine transport (GO:0015879) | 3.40862179 |
115 | amino-acid betaine transport (GO:0015838) | 3.40862179 |
116 | regulation of muscle contraction (GO:0006937) | 3.39404685 |
117 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.38621796 |
118 | cardiac chamber formation (GO:0003207) | 3.38271567 |
119 | muscle organ development (GO:0007517) | 3.37365441 |
120 | muscle fiber development (GO:0048747) | 3.37305463 |
121 | muscle structure development (GO:0061061) | 3.36698129 |
122 | positive regulation of cation channel activity (GO:2001259) | 3.35457992 |
123 | cardiac conduction (GO:0061337) | 3.35319474 |
124 | skeletal muscle tissue regeneration (GO:0043403) | 3.35209541 |
125 | response to muscle activity (GO:0014850) | 3.32915937 |
126 | positive regulation of myotube differentiation (GO:0010831) | 3.32492717 |
127 | cellular polysaccharide catabolic process (GO:0044247) | 3.32135828 |
128 | striated muscle atrophy (GO:0014891) | 3.30692883 |
129 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.30644234 |
130 | regulation of myoblast differentiation (GO:0045661) | 3.26789960 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.27899419 |
2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.50593099 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.28779118 |
4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.30460421 |
5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.27453673 |
6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.27453673 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.99076814 |
8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.86232697 |
9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.84590639 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.74719094 |
11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.53661653 |
12 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.87004437 |
13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.77370525 |
14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.70147692 |
15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57394310 |
16 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.20991242 |
17 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.19595189 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15791118 |
19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12426707 |
20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.09160798 |
21 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.99301712 |
22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.89362693 |
23 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.85603594 |
24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.82891435 |
25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.78058045 |
26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.67895628 |
27 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.63150008 |
28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58836623 |
29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.51283627 |
30 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45835188 |
31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44067971 |
32 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.43534527 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43046742 |
34 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.39317476 |
35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38724182 |
36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33510461 |
37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26159125 |
38 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.25979773 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25451284 |
40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25267705 |
41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.24372232 |
42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22198885 |
43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21574136 |
44 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.18661037 |
45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15060310 |
46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12499656 |
47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12159235 |
48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11778166 |
49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11551640 |
50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09612471 |
51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09612471 |
52 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.08897844 |
53 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.08221001 |
54 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08136447 |
55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07093951 |
56 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06487055 |
57 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06486022 |
58 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06048181 |
59 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05777685 |
60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04872560 |
61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04750120 |
62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03467431 |
63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03217568 |
64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02709908 |
65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02337708 |
66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01564241 |
67 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01048562 |
68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00694029 |
69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99634455 |
70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97922208 |
71 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95254952 |
72 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.94222073 |
73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93654586 |
74 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93481713 |
75 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93312840 |
76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92856613 |
77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92713515 |
78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.91825517 |
79 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.91292996 |
80 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90202872 |
81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89962554 |
82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89781827 |
83 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89722780 |
84 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89373245 |
85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89010800 |
86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88873441 |
87 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88812165 |
88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88511287 |
89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88267219 |
90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87352349 |
91 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86600264 |
92 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86528795 |
93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86398483 |
94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86281931 |
95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85872470 |
96 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82857855 |
97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82401880 |
98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81306585 |
99 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.81203530 |
100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.80926312 |
101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.80801190 |
102 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80244591 |
103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80076624 |
104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79840857 |
105 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.79827289 |
106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79455438 |
107 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78806966 |
108 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.78140913 |
109 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77624046 |
110 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.77199421 |
111 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.77044696 |
112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76948947 |
113 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76880976 |
114 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.76007352 |
115 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.75729480 |
116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75528751 |
117 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.75406602 |
118 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74923320 |
119 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.73954818 |
120 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73622689 |
121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.73602339 |
122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73480824 |
123 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.73065709 |
124 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.72738190 |
125 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72649224 |
126 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.72191060 |
127 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71981555 |
128 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.71632499 |
129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.71553890 |
130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.71517185 |
131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.71504867 |
132 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71299051 |
133 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.69701520 |
134 | VDR_22108803_ChIP-Seq_LS180_Human | 0.69170028 |
135 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.67944105 |
136 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67301708 |
137 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.67268502 |
138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66944652 |
139 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.66603975 |
140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66338358 |
141 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.65818927 |
142 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.64959689 |
143 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.63871681 |
144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.63351873 |
145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62152453 |
146 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62152453 |
147 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.61672653 |
148 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.60543743 |
149 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59723414 |
150 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59402959 |
151 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.59323517 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004084_abnormal_cardiac_muscle | 5.76561705 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 5.56138881 |
3 | MP0003646_muscle_fatigue | 5.36156973 |
4 | MP0000751_myopathy | 5.15939128 |
5 | MP0000749_muscle_degeneration | 4.86490243 |
6 | MP0004036_abnormal_muscle_relaxation | 4.67040759 |
7 | MP0004215_abnormal_myocardial_fiber | 4.29930879 |
8 | MP0005330_cardiomyopathy | 3.90895817 |
9 | MP0004145_abnormal_muscle_electrophysio | 3.64638727 |
10 | MP0004087_abnormal_muscle_fiber | 3.35136085 |
11 | MP0002972_abnormal_cardiac_muscle | 3.17099285 |
12 | MP0005620_abnormal_muscle_contractility | 3.03863606 |
13 | MP0002106_abnormal_muscle_physiology | 3.00131109 |
14 | MP0000750_abnormal_muscle_regeneration | 2.85742878 |
15 | MP0008775_abnormal_heart_ventricle | 2.83573085 |
16 | MP0003137_abnormal_impulse_conducting | 2.70314211 |
17 | MP0010630_abnormal_cardiac_muscle | 2.60301101 |
18 | MP0002269_muscular_atrophy | 2.58964095 |
19 | MP0004130_abnormal_muscle_cell | 2.57266742 |
20 | MP0001544_abnormal_cardiovascular_syste | 2.50262416 |
21 | MP0005385_cardiovascular_system_phenoty | 2.50262416 |
22 | MP0000747_muscle_weakness | 2.49785558 |
23 | MP0005369_muscle_phenotype | 2.43270374 |
24 | MP0004484_altered_response_of | 2.38810814 |
25 | MP0000759_abnormal_skeletal_muscle | 2.34021010 |
26 | MP0006138_congestive_heart_failure | 2.24555530 |
27 | MP0003828_pulmonary_edema | 2.21844232 |
28 | MP0003221_abnormal_cardiomyocyte_apopto | 2.11648081 |
29 | MP0004233_abnormal_muscle_weight | 2.11578967 |
30 | MP0006036_abnormal_mitochondrial_physio | 1.99614584 |
31 | MP0003950_abnormal_plasma_membrane | 1.95941375 |
32 | MP0004085_abnormal_heartbeat | 1.93285315 |
33 | MP0002127_abnormal_cardiovascular_syste | 1.78590048 |
34 | MP0004510_myositis | 1.76852591 |
35 | MP0002332_abnormal_exercise_endurance | 1.63227323 |
36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.54466881 |
37 | MP0004270_analgesia | 1.16988763 |
38 | MP0006035_abnormal_mitochondrial_morpho | 1.16414431 |
39 | MP0000266_abnormal_heart_morphology | 1.14691034 |
40 | MP0005666_abnormal_adipose_tissue | 1.13285489 |
41 | MP0002234_abnormal_pharynx_morphology | 1.09809349 |
42 | MP0001661_extended_life_span | 1.05822059 |
43 | MP0000733_abnormal_muscle_development | 1.04876156 |
44 | MP0002108_abnormal_muscle_morphology | 1.03096983 |
45 | MP0000343_altered_response_to | 0.98085834 |
46 | MP0005266_abnormal_metabolism | 0.88225984 |
47 | MP0005165_increased_susceptibility_to | 0.85262393 |
48 | MP0004185_abnormal_adipocyte_glucose | 0.83778607 |
49 | MP0005451_abnormal_body_composition | 0.82806426 |
50 | MP0003279_aneurysm | 0.81071331 |
51 | MP0003806_abnormal_nucleotide_metabolis | 0.78165325 |
52 | MP0002822_catalepsy | 0.76008769 |
53 | MP0005375_adipose_tissue_phenotype | 0.73868316 |
54 | MP0000230_abnormal_systemic_arterial | 0.72653577 |
55 | MP0003045_fibrosis | 0.72555531 |
56 | MP0005670_abnormal_white_adipose | 0.71852800 |
57 | MP0002128_abnormal_blood_circulation | 0.71825894 |
58 | MP0003566_abnormal_cell_adhesion | 0.68346170 |
59 | MP0002971_abnormal_brown_adipose | 0.67739003 |
60 | MP0010368_abnormal_lymphatic_system | 0.67109316 |
61 | MP0004272_abnormal_basement_membrane | 0.64242780 |
62 | MP0004043_abnormal_pH_regulation | 0.60929897 |
63 | MP0003705_abnormal_hypodermis_morpholog | 0.60606526 |
64 | MP0005377_hearing/vestibular/ear_phenot | 0.60480468 |
65 | MP0003878_abnormal_ear_physiology | 0.60480468 |
66 | MP0000013_abnormal_adipose_tissue | 0.58220268 |
67 | MP0009384_cardiac_valve_regurgitation | 0.57460056 |
68 | MP0005275_abnormal_skin_tensile | 0.56885866 |
69 | MP0004147_increased_porphyrin_level | 0.54589136 |
70 | MP0008569_lethality_at_weaning | 0.52966073 |
71 | MP0005623_abnormal_meninges_morphology | 0.51854551 |
72 | MP0001299_abnormal_eye_distance/ | 0.50480159 |
73 | MP0000767_abnormal_smooth_muscle | 0.48425766 |
74 | MP0002925_abnormal_cardiovascular_devel | 0.46470990 |
75 | MP0001879_abnormal_lymphatic_vessel | 0.45197045 |
76 | MP0003984_embryonic_growth_retardation | 0.43488212 |
77 | MP0002088_abnormal_embryonic_growth/wei | 0.43307668 |
78 | MP0000372_irregular_coat_pigmentation | 0.43142057 |
79 | MP0009780_abnormal_chondrocyte_physiolo | 0.42369235 |
80 | MP0002638_abnormal_pupillary_reflex | 0.42157567 |
81 | MP0001784_abnormal_fluid_regulation | 0.40928743 |
82 | MP0000003_abnormal_adipose_tissue | 0.40024257 |
83 | MP0005319_abnormal_enzyme/_coenzyme | 0.40002238 |
84 | MP0002078_abnormal_glucose_homeostasis | 0.37369764 |
85 | MP0008438_abnormal_cutaneous_collagen | 0.36633752 |
86 | MP0001614_abnormal_blood_vessel | 0.34245281 |
87 | MP0005167_abnormal_blood-brain_barrier | 0.33011208 |
88 | MP0001727_abnormal_embryo_implantation | 0.32595652 |
89 | MP0003948_abnormal_gas_homeostasis | 0.32289616 |
90 | MP0005187_abnormal_penis_morphology | 0.30481571 |
91 | MP0003879_abnormal_hair_cell | 0.29369503 |
92 | MP0003122_maternal_imprinting | 0.28863148 |
93 | MP0002909_abnormal_adrenal_gland | 0.28124240 |
94 | MP0008961_abnormal_basal_metabolism | 0.27806171 |
95 | MP0000762_abnormal_tongue_morphology | 0.26256674 |
96 | MP0004142_abnormal_muscle_tone | 0.26006580 |
97 | MP0003941_abnormal_skin_development | 0.25990018 |
98 | MP0004134_abnormal_chest_morphology | 0.25402688 |
99 | MP0009250_abnormal_appendicular_skeleto | 0.25288721 |
100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.23903909 |
101 | MP0005423_abnormal_somatic_nervous | 0.23650114 |
102 | MP0001984_abnormal_olfaction | 0.23548434 |
103 | MP0005380_embryogenesis_phenotype | 0.22573507 |
104 | MP0001672_abnormal_embryogenesis/_devel | 0.22573507 |
105 | MP0005332_abnormal_amino_acid | 0.22184517 |
106 | MP0005503_abnormal_tendon_morphology | 0.20876997 |
107 | MP0005535_abnormal_body_temperature | 0.20740094 |
108 | MP0008874_decreased_physiological_sensi | 0.20489963 |
109 | MP0002114_abnormal_axial_skeleton | 0.19934554 |
110 | MP0003123_paternal_imprinting | 0.19619715 |
111 | MP0004924_abnormal_behavior | 0.19402537 |
112 | MP0005386_behavior/neurological_phenoty | 0.19402537 |
113 | MP0010030_abnormal_orbit_morphology | 0.18735127 |
114 | MP0005595_abnormal_vascular_smooth | 0.18590611 |
115 | MP0005334_abnormal_fat_pad | 0.18085580 |
116 | MP0005452_abnormal_adipose_tissue | 0.18050239 |
117 | MP0003385_abnormal_body_wall | 0.17775344 |
118 | MP0005166_decreased_susceptibility_to | 0.17680923 |
119 | MP0009672_abnormal_birth_weight | 0.17042014 |
120 | MP0001485_abnormal_pinna_reflex | 0.16628739 |
121 | MP0002066_abnormal_motor_capabilities/c | 0.16622560 |
122 | MP0005376_homeostasis/metabolism_phenot | 0.16544834 |
123 | MP0002734_abnormal_mechanical_nocicepti | 0.16441207 |
124 | MP0005388_respiratory_system_phenotype | 0.16311297 |
125 | MP0002133_abnormal_respiratory_system | 0.16311297 |
126 | MP0003195_calcinosis | 0.15689476 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 7.11258505 |
2 | Exercise-induced muscle cramps (HP:0003710) | 6.98321931 |
3 | Exercise-induced myalgia (HP:0003738) | 6.88755709 |
4 | Calf muscle hypertrophy (HP:0008981) | 6.77977210 |
5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.48587840 |
6 | Ventricular tachycardia (HP:0004756) | 5.82908919 |
7 | Subaortic stenosis (HP:0001682) | 5.34510325 |
8 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.34510325 |
9 | Muscle fiber splitting (HP:0003555) | 5.34409054 |
10 | Abnormality of the calf musculature (HP:0001430) | 5.30713565 |
11 | Hyporeflexia of lower limbs (HP:0002600) | 5.19779347 |
12 | Muscle fiber inclusion bodies (HP:0100299) | 5.14290355 |
13 | Atrial fibrillation (HP:0005110) | 5.11329525 |
14 | Myoglobinuria (HP:0002913) | 5.07113982 |
15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.02770398 |
16 | Primary atrial arrhythmia (HP:0001692) | 4.76454974 |
17 | Lipoatrophy (HP:0100578) | 4.72304173 |
18 | Type 1 muscle fiber predominance (HP:0003803) | 4.64202934 |
19 | Supraventricular tachycardia (HP:0004755) | 4.60758880 |
20 | EMG: myopathic abnormalities (HP:0003458) | 4.57911615 |
21 | Nemaline bodies (HP:0003798) | 4.57212600 |
22 | Supraventricular arrhythmia (HP:0005115) | 4.50939145 |
23 | Right ventricular cardiomyopathy (HP:0011663) | 4.26266739 |
24 | Rhabdomyolysis (HP:0003201) | 4.09431312 |
25 | Syncope (HP:0001279) | 4.03606905 |
26 | Asymmetric septal hypertrophy (HP:0001670) | 4.02090214 |
27 | Dilated cardiomyopathy (HP:0001644) | 3.95839975 |
28 | Palpitations (HP:0001962) | 3.89970996 |
29 | Ventricular arrhythmia (HP:0004308) | 3.80248184 |
30 | Increased connective tissue (HP:0009025) | 3.75447973 |
31 | Prolonged QT interval (HP:0001657) | 3.75291686 |
32 | Difficulty running (HP:0009046) | 3.72500804 |
33 | Bundle branch block (HP:0011710) | 3.56436142 |
34 | Myotonia (HP:0002486) | 3.48231852 |
35 | Calcaneovalgus deformity (HP:0001848) | 3.40731348 |
36 | Distal arthrogryposis (HP:0005684) | 3.28563618 |
37 | Muscle stiffness (HP:0003552) | 3.23003827 |
38 | Neck muscle weakness (HP:0000467) | 3.16985537 |
39 | Ventricular fibrillation (HP:0001663) | 3.09704252 |
40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.01119330 |
41 | Heart block (HP:0012722) | 3.00580890 |
42 | Deformed tarsal bones (HP:0008119) | 3.00514810 |
43 | Acute necrotizing encephalopathy (HP:0006965) | 3.00486579 |
44 | Distal lower limb muscle weakness (HP:0009053) | 2.84665300 |
45 | Abnormal atrioventricular conduction (HP:0005150) | 2.82639722 |
46 | Malignant hyperthermia (HP:0002047) | 2.81266962 |
47 | Round ear (HP:0100830) | 2.79672712 |
48 | Areflexia of lower limbs (HP:0002522) | 2.78618615 |
49 | Difficulty climbing stairs (HP:0003551) | 2.75632300 |
50 | Atrioventricular block (HP:0001678) | 2.74902292 |
51 | Myopathic facies (HP:0002058) | 2.73264142 |
52 | Abnormal EKG (HP:0003115) | 2.73237703 |
53 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.72594287 |
54 | Hepatic necrosis (HP:0002605) | 2.72412788 |
55 | Left ventricular hypertrophy (HP:0001712) | 2.69517422 |
56 | Rimmed vacuoles (HP:0003805) | 2.68635753 |
57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.65603582 |
58 | Ragged-red muscle fibers (HP:0003200) | 2.63379789 |
59 | Conjunctival hamartoma (HP:0100780) | 2.62822192 |
60 | Abnormal finger flexion creases (HP:0006143) | 2.62242340 |
61 | Distal lower limb amyotrophy (HP:0008944) | 2.55249365 |
62 | Bulbar palsy (HP:0001283) | 2.54800942 |
63 | Fetal akinesia sequence (HP:0001989) | 2.54377916 |
64 | Weak cry (HP:0001612) | 2.53128146 |
65 | Acute encephalopathy (HP:0006846) | 2.51981525 |
66 | Progressive macrocephaly (HP:0004481) | 2.48479434 |
67 | Generalized muscle weakness (HP:0003324) | 2.42522848 |
68 | Palmoplantar keratoderma (HP:0000982) | 2.41164719 |
69 | Exercise intolerance (HP:0003546) | 2.39579252 |
70 | Abnormality of the neuromuscular junction (HP:0003398) | 2.38406268 |
71 | Fatigable weakness (HP:0003473) | 2.38406268 |
72 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.37719351 |
73 | Mitochondrial inheritance (HP:0001427) | 2.37194233 |
74 | Hip contracture (HP:0003273) | 2.35641443 |
75 | EMG: neuropathic changes (HP:0003445) | 2.34505825 |
76 | Hepatocellular necrosis (HP:0001404) | 2.32221692 |
77 | Increased CSF lactate (HP:0002490) | 2.31635464 |
78 | Hypoglycemic coma (HP:0001325) | 2.31246299 |
79 | Ulnar deviation of the wrist (HP:0003049) | 2.29719913 |
80 | Abnormality of glycolysis (HP:0004366) | 2.25832903 |
81 | Increased serum pyruvate (HP:0003542) | 2.25832903 |
82 | Pheochromocytoma (HP:0002666) | 2.25020900 |
83 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22834682 |
84 | Cerebral edema (HP:0002181) | 2.21064022 |
85 | Ketoacidosis (HP:0001993) | 2.13198894 |
86 | Gowers sign (HP:0003391) | 2.12921729 |
87 | Popliteal pterygium (HP:0009756) | 2.12078384 |
88 | Abnormality of alanine metabolism (HP:0010916) | 2.09780402 |
89 | Hyperalaninemia (HP:0003348) | 2.09780402 |
90 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.09780402 |
91 | Hypoplastic ischia (HP:0003175) | 2.08877992 |
92 | Increased muscle lipid content (HP:0009058) | 2.07459458 |
93 | Limb-girdle muscle atrophy (HP:0003797) | 2.04367410 |
94 | Neuroendocrine neoplasm (HP:0100634) | 2.03861669 |
95 | Muscular dystrophy (HP:0003560) | 2.01390419 |
96 | Abnormality of the foot musculature (HP:0001436) | 2.01142117 |
97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00698596 |
98 | Dicarboxylic aciduria (HP:0003215) | 2.00698596 |
99 | Lactic acidosis (HP:0003128) | 2.00250347 |
100 | Neoplasm of the adrenal gland (HP:0100631) | 1.98494573 |
101 | Slender build (HP:0001533) | 1.98057233 |
102 | Proximal amyotrophy (HP:0007126) | 1.97867241 |
103 | Waddling gait (HP:0002515) | 1.97502934 |
104 | Type 2 muscle fiber atrophy (HP:0003554) | 1.96650843 |
105 | Lower limb amyotrophy (HP:0007210) | 1.94917285 |
106 | Progressive muscle weakness (HP:0003323) | 1.94445614 |
107 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94112761 |
108 | Scapular winging (HP:0003691) | 1.93935732 |
109 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.93186629 |
110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.92495260 |
111 | Facial diplegia (HP:0001349) | 1.92425228 |
112 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90630900 |
113 | Frequent falls (HP:0002359) | 1.90080714 |
114 | Hamartoma of the eye (HP:0010568) | 1.89490557 |
115 | Double outlet right ventricle (HP:0001719) | 1.88979620 |
116 | Congenital malformation of the right heart (HP:0011723) | 1.88979620 |
117 | Spinal rigidity (HP:0003306) | 1.88706357 |
118 | Respiratory failure (HP:0002878) | 1.88233009 |
119 | Abnormality of the calcaneus (HP:0008364) | 1.88150540 |
120 | Foot dorsiflexor weakness (HP:0009027) | 1.84599187 |
121 | Hyperkalemia (HP:0002153) | 1.84232903 |
122 | Absent phalangeal crease (HP:0006109) | 1.82398403 |
123 | Muscle fiber atrophy (HP:0100295) | 1.78303945 |
124 | Steppage gait (HP:0003376) | 1.77795197 |
125 | Aplasia of the musculature (HP:0100854) | 1.64824919 |
126 | Limited hip movement (HP:0008800) | 1.64772401 |
127 | Limb-girdle muscle weakness (HP:0003325) | 1.60558873 |
128 | Hypoplastic heart (HP:0001961) | 1.56796780 |
129 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.48902615 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 7.30631562 |
2 | TTN | 5.44249647 |
3 | PHKG2 | 3.81090623 |
4 | PHKG1 | 3.81090623 |
5 | PDK3 | 3.45607694 |
6 | PDK4 | 3.45607694 |
7 | MYLK | 3.43170233 |
8 | STK24 | 3.31142793 |
9 | PKN2 | 2.83707544 |
10 | DMPK | 2.77349398 |
11 | NEK1 | 2.71929738 |
12 | LMTK2 | 2.50587533 |
13 | PIK3CA | 2.31925932 |
14 | TRIB3 | 2.30182942 |
15 | PDK2 | 2.09546434 |
16 | MUSK | 2.03487702 |
17 | BCKDK | 2.01902508 |
18 | PINK1 | 1.76610365 |
19 | ZAK | 1.57477231 |
20 | TIE1 | 1.55746362 |
21 | ILK | 1.44473764 |
22 | MAP2K3 | 1.40183759 |
23 | PIK3CG | 1.30847717 |
24 | NME1 | 1.29234267 |
25 | MAP3K7 | 1.28874068 |
26 | STK38L | 1.25867139 |
27 | MARK1 | 1.22881085 |
28 | MAPK12 | 1.16101370 |
29 | TRPM7 | 1.11558226 |
30 | CDC42BPA | 1.09483745 |
31 | PAK3 | 0.97367454 |
32 | GRK7 | 0.94867573 |
33 | CAMK2D | 0.94035530 |
34 | WNK4 | 0.92111382 |
35 | LIMK1 | 0.91786135 |
36 | MAPKAPK3 | 0.91322803 |
37 | PRKD1 | 0.89151847 |
38 | ROCK1 | 0.88046360 |
39 | CCNB1 | 0.84399383 |
40 | EEF2K | 0.82120297 |
41 | MAP3K3 | 0.80237718 |
42 | FLT3 | 0.79687407 |
43 | PRKAA1 | 0.79621282 |
44 | PRKAA2 | 0.78521254 |
45 | MAP3K5 | 0.74111858 |
46 | DAPK3 | 0.72448790 |
47 | MOS | 0.71036505 |
48 | STK4 | 0.63269577 |
49 | INSRR | 0.62714366 |
50 | STK39 | 0.59503751 |
51 | NEK9 | 0.58747874 |
52 | MAPK4 | 0.56143575 |
53 | WNK1 | 0.54985952 |
54 | ERBB3 | 0.54097791 |
55 | RIPK1 | 0.53774258 |
56 | PKN1 | 0.53690693 |
57 | MAP2K4 | 0.53146435 |
58 | CAMK2B | 0.51826516 |
59 | CAMK4 | 0.51631149 |
60 | TAOK2 | 0.49296563 |
61 | AKT2 | 0.48896272 |
62 | PTK2B | 0.48701383 |
63 | NME2 | 0.47889350 |
64 | DYRK1B | 0.47521681 |
65 | CAMK1 | 0.46164543 |
66 | PRKACB | 0.45491307 |
67 | CAMK2A | 0.44870501 |
68 | MAP2K6 | 0.41486609 |
69 | CAMK2G | 0.41225790 |
70 | KSR2 | 0.40955460 |
71 | STK38 | 0.39597358 |
72 | ROCK2 | 0.39540735 |
73 | MAP3K10 | 0.39003486 |
74 | PRKD3 | 0.35717314 |
75 | MAP3K13 | 0.34134805 |
76 | PDGFRA | 0.34067301 |
77 | PRKACA | 0.33187835 |
78 | SGK3 | 0.31519553 |
79 | KDR | 0.30778991 |
80 | RPS6KC1 | 0.30729963 |
81 | RPS6KL1 | 0.30729963 |
82 | MAP3K6 | 0.29766810 |
83 | TGFBR2 | 0.29253873 |
84 | LATS1 | 0.28870604 |
85 | PTK6 | 0.27672995 |
86 | EPHA3 | 0.24958185 |
87 | SGK2 | 0.24945345 |
88 | SIK1 | 0.24612472 |
89 | PRKACG | 0.24367136 |
90 | MARK3 | 0.24285997 |
91 | PDPK1 | 0.23130997 |
92 | MAPK10 | 0.23001107 |
93 | PDK1 | 0.22887515 |
94 | RPS6KA6 | 0.22764549 |
95 | PRKG1 | 0.21918202 |
96 | MAP3K11 | 0.20769377 |
97 | MAPK11 | 0.20457580 |
98 | RPS6KB2 | 0.18866133 |
99 | ICK | 0.17896181 |
100 | RPS6KA1 | 0.17269495 |
101 | MARK2 | 0.16973129 |
102 | MAP3K1 | 0.16898061 |
103 | PRKCE | 0.16448121 |
104 | FGFR1 | 0.16050581 |
105 | PRPF4B | 0.15254018 |
106 | LATS2 | 0.15223930 |
107 | EPHB1 | 0.14962976 |
108 | ARAF | 0.14927656 |
109 | RPS6KB1 | 0.14002991 |
110 | EPHB2 | 0.13754471 |
111 | MAPK7 | 0.12679662 |
112 | SGK1 | 0.12516463 |
113 | ZAP70 | 0.12251316 |
114 | LRRK2 | 0.12196912 |
115 | RPS6KA3 | 0.11593403 |
116 | RAF1 | 0.10256524 |
117 | PRKCQ | 0.10028766 |
118 | MAP3K12 | 0.09933781 |
119 | DAPK2 | 0.09859886 |
120 | STK3 | 0.09619637 |
121 | STK11 | 0.09095367 |
122 | MAPKAPK2 | 0.09076958 |
123 | MAP2K1 | 0.08820123 |
124 | FER | 0.07385699 |
125 | PRKG2 | 0.07190360 |
126 | MTOR | 0.06793781 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.21288754 |
2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.76109651 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.10995119 |
4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.83797541 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.72346261 |
6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.66525719 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.47003387 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.06566929 |
9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.65442867 |
10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.58128858 |
11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.57138961 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55198014 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51209203 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.37158869 |
15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.33715021 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04407565 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90172158 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87645795 |
19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.86105961 |
20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.66743831 |
21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55990453 |
22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46441621 |
23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29722287 |
24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22750486 |
25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.22273262 |
26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22162193 |
27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11037105 |
28 | Insulin resistance_Homo sapiens_hsa04931 | 1.10008223 |
29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03141508 |
30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01899439 |
31 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91304009 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88698174 |
33 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86160815 |
34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82790534 |
35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82317489 |
36 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81018203 |
37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79959288 |
38 | Tight junction_Homo sapiens_hsa04530 | 0.79789655 |
39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78866872 |
40 | Focal adhesion_Homo sapiens_hsa04510 | 0.76816477 |
41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75327867 |
42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72407868 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71272758 |
44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.68877160 |
45 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68046998 |
46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66327421 |
47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65570499 |
48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63342807 |
49 | Salivary secretion_Homo sapiens_hsa04970 | 0.59981633 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57779787 |
51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53272986 |
52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52015719 |
53 | Lysine degradation_Homo sapiens_hsa00310 | 0.48172089 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48010779 |
55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47105376 |
56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40989812 |
57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39684135 |
58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39557563 |
59 | Peroxisome_Homo sapiens_hsa04146 | 0.37918846 |
60 | Adherens junction_Homo sapiens_hsa04520 | 0.36111034 |
61 | Long-term depression_Homo sapiens_hsa04730 | 0.35556224 |
62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35507790 |
63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35418961 |
64 | Renin secretion_Homo sapiens_hsa04924 | 0.34671562 |
65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34245933 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33100075 |
67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32135937 |
68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31778060 |
69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29309456 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27065206 |
71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26305979 |
72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26236482 |
73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25851017 |
74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25779919 |
75 | Amoebiasis_Homo sapiens_hsa05146 | 0.24458562 |
76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24187314 |
77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22363972 |
78 | Insulin secretion_Homo sapiens_hsa04911 | 0.22176446 |
79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21890424 |
80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20080853 |
81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19552202 |
82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19401759 |
83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17865501 |
84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.17728578 |
85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17575041 |
86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17507827 |
87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17435678 |
88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16969748 |
89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.16861148 |
90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14974291 |
91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14821801 |
92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.12133868 |
93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.11167882 |
94 | Platelet activation_Homo sapiens_hsa04611 | 0.11048789 |
95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.10413426 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09534855 |
97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08897716 |
98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.08793035 |
99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.08714037 |
100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.06483786 |
101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.05923210 |
102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02787236 |
103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.00805417 |
104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0641231 |
105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | -0.0526102 |
106 | Melanogenesis_Homo sapiens_hsa04916 | -0.0514510 |
107 | Bile secretion_Homo sapiens_hsa04976 | -0.0499683 |
108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0368421 |
109 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0313296 |
110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0297424 |
111 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0264544 |
112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0125090 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0122554 |
114 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0115138 |
115 | Gap junction_Homo sapiens_hsa04540 | -0.0066045 |